25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30765600 | Cytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer. | 2019 Apr 1 | 1 |
2 | 28485511 | Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP. | 2017 Oct | 1 |
3 | 26263379 | Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer. | 2015 | 1 |
4 | 24741455 | Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells. | 2014 Mar | 1 |
5 | 24925528 | Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer. | 2014 Oct 15 | 1 |
6 | 23038213 | Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. | 2013 Apr | 1 |
7 | 23138939 | γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products. | 2013 Jan | 4 |
8 | 21982118 | Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. | 2011 Oct 7 | 5 |
9 | 19850643 | Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. | 2010 Apr | 1 |
10 | 20056115 | Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. | 2010 Apr 10 | 2 |
11 | 20618955 | NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells. | 2010 Jul 9 | 5 |
12 | 19414318 | A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. | 2009 Mar | 7 |
13 | 19531569 | Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. | 2009 Jun | 1 |
14 | 19834284 | Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB. | 2009 Oct | 1 |
15 | 18426800 | The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. | 2008 Jul 25 | 2 |
16 | 19050703 | Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer. | 2008 Dec 16 | 1 |
17 | 17638896 | Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. | 2007 Jul 15 | 2 |
18 | 17913854 | Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. | 2007 Oct | 5 |
19 | 16613577 | The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. | 2006 Apr | 1 |
20 | 16622259 | Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. | 2006 Apr 20 | 1 |
21 | 15956258 | The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. | 2005 Jun | 1 |
22 | 16061678 | Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. | 2005 Aug 1 | 1 |
23 | 15097869 | Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. | 2004 May | 2 |
24 | 12687011 | PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. | 2003 Apr 10 | 6 |
25 | 14614027 | Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. | 2003 Nov 1 | 1 |